Organization: Health Canada
Year: 2024
Month: March
Request Number: A-2023-000619
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practice (GMP) inspection of the Novo Nordisk Canada facility (Site A) on Argentina Rd, Mississauga, Ontario, starting around 03/20/2019.
Disposition: Disclosed in part
Number of pages: 115